ReviewDrug delivery and translational research2024
Gut microbiome as therapeutic target for diabesity management: opportunity for nanonutraceuticals and associated challenges.
Priyanka Rathod et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it